Apremilast decreased lesion counts in moderate to severe lichen planus, and topical pimecrolimus improved recalcitrant lesions of dermatomyositis.
Welcome to Journal Watch. The content you requested requires sign in with a username and password.
Activate your free online account for full access to all site content and features.
Subscribe for full access to all site content and features. ($99/year)
Purchase a site pass for full access to all articles. ($19/7 days)
Or, simply register for free access to email alerts, site features, and article archives. (FREE)